A report from investigative group Open the Books found that scientists with the National Institutes of Health (NIH) were paid around $710 million from big pharma groups during the COVID-19 pandemic.
Last week, Moderna announced that it has received approval from the Food and Drug Administration (FDA) for the development of an mRNA vaccine for respiratory syncytial virus (RSV).
Data from U.S. Customs and Border Protection (CBP) suggests that border crossings between British Columbia and Washington are set to quadruple from 2021.
Former National Institute of Allergy and Infectious Diseases (NIAID) director Dr. Anthony Fauci appeared in front of the Committee on Oversight and Accountability in January to testify on COVID-19, the transcripts of which were recently released.
In a world increasingly shaped by global health emergencies, it seems like we’re seeing the same playbook unfold again—this time with the virus known as monkeypox.